Reply to Suissa and Ariel: The FULFIL Trial. (2018)
Attributed to:
Alpha-1-antitrypsin (AT) deficiency and the serpinopathies: pathobiology and new therapeutic strategies
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1164/rccm.201709-1831le
PubMed Identifier: 28950068
Publication URI: http://europepmc.org/abstract/MED/28950068
Type: Journal Article/Review
Volume: 197
Parent Publication: American journal of respiratory and critical care medicine
Issue: 4
ISSN: 1073-449X